Litigation Details for Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
✉ Email this page to a colleague
Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-06-20 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 10,143,693; 8,022,036; 9,439,906 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd.
Biologic Drugs cited in Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd.
Details for Janssen Pharmaceuticals, Inc. v. Mylan Laboratories Ltd. (Fed. Cir. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-03-11 | 22 | launch. [1] From U.S. Patent No. 10,143,693; https://patents.google.com/patent/US10143693B2/en?oq=10%…-7 and 9-14 of United States Patent No. 10,143,693 (“the ’693 patent”) and Mylan’s products that are…Hatch-Waxman case involving Janssen’s U.S. Patent No. 10,143,693 (the “693 Patent”), listed in the Orange Book for…Claims 1-3, 5-7, and 9-29 of U.S. Patent No. 10,143,693 (the “693 Patent”). 15. It … “Plaintiffs”) concerning U.S. Patent No. 10,143,693 (“the ’693 patent”). In their Disclosures of Asserted | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |